ClinicalTrials.gg
RecruitingNCT07715786Updated Jul 20, 2026

Blood Flow Restriction During Nordic Hamstring Exercise in Elite Adolescent Athletes

An interventional study of Nordic Hamstring Exercise and Blood Flow Restriction Nordic Hamstring Exercise in Healthy Volunteers (HV), sponsored by Toros University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 14 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-20.

Sponsored by Toros University · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Jul 2026; still recruiting 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
14 Years to 18 Years
Sex
All
01

Study summary

This crossover experimental study aims to compare acute hamstring muscle oxygenation responses during Nordic Hamstring Exercise (NHE) and Blood Flow Restriction Nordic Hamstring Exercise (BFR-NHE) in elite adolescent athletes. Participants will complete both exercise conditions in a randomized order separated by a 7-day washout period. Muscle oxygen saturation will be assessed using near-infrared spectroscopy (MOXY), together with total hemoglobin responses, blood lactate concentration, perceived exertion, and exercise performance variables. The findings may improve understanding of the physiological effects of blood flow restriction during eccentric hamstring exercise in adolescent athletes.

Read the detailed description

Hamstring muscles play a crucial role in sprinting, jumping, change-of-direction movements, and other high-intensity athletic activities. Nordic Hamstring Exercise (NHE) is one of the most effective eccentric strengthening exercises for improving hamstring function and reducing the risk of hamstring strain injuries. Recently, blood flow restriction (BFR) training has gained increasing attention because it may enhance metabolic stress and alter muscle oxygenation responses during exercise. However, evidence regarding the acute physiological effects of combining BFR with Nordic Hamstring Exercise in elite adolescent athletes remains limited.

This study aims to compare hamstring muscle oxygenation responses during conventional Nordic Hamstring Exercise and Blood Flow Restriction Nordic Hamstring Exercise in elite adolescent athletes. A prospective crossover experimental design will be used, allowing each participant to complete both exercise conditions and serve as his or her own control. The order of the interventions will be randomized, and the two testing sessions will be separated by a 7-day washout period to minimize potential carryover effects.

Elite adolescent athletes aged 14-18 years who have participated in regular training for at least three years will be recruited. During each testing session, hamstring muscle oxygen saturation (SmO₂) and total hemoglobin (tHb) responses will be continuously monitored using wearable near-infrared spectroscopy (MOXY). Measurements will include baseline SmO₂, minimum SmO₂, delta SmO₂, recovery SmO₂, baseline total hemoglobin, peak total hemoglobin, and delta total hemoglobin. Blood lactate concentration, rating of perceived exertion using the Borg Rating of Perceived Exertion Scale, exercise performance variables, and post-exercise symptoms such as muscle soreness and fatigue will also be recorded.

Nordic Hamstring Exercise will be performed according to a standardized protocol under physiotherapist supervision. During the Blood Flow Restriction Nordic Hamstring Exercise condition, the same exercise protocol will be performed while individualized blood flow restriction is applied to the proximal lower extremity using a pneumatic cuff. The cuff pressure will be individualized based on participant tolerance and safety, and the intervention will be discontinued immediately if any adverse symptoms occur.

The primary objective is to determine whether blood flow restriction alters acute hamstring muscle oxygenation responses during Nordic Hamstring Exercise. Secondary objectives include comparing total hemoglobin responses, blood lactate concentration, perceived exertion, exercise performance, and post-exercise recovery between the two exercise conditions. The findings of this study are expected to improve understanding of the physiological mechanisms of blood flow restriction during eccentric hamstring exercise and provide evidence for its safe and effective use in adolescent athletic populations.

02

Conditions studied

  • Healthy Volunteers (HV)

Keywords

  • Nordic Hamstring Exercise
  • Blood Flow Restriction
  • Elite Adolescent Athletes
  • Muscle Oxygenation
03

In context

Lead sponsor

Toros University is the lead sponsor of 21 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
14 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Elite adolescent athletes aged 14 to 18 years.
  • Licensed athletes with at least 3 years of regular sports participation.
  • Currently participating in a regular weekly training program.
  • Physically able to complete the Nordic Hamstring Exercise and study testing protocol.
  • Willing to participate in the study.
  • Able to provide written .
  • For participants younger than 18 years, written informed consent provided by a parent or legal guardian and assent provided by the participant.

Exclusion criteria

Exclusion Criteria:

  • Hamstring injury within the previous 6 months.
  • Lower extremity surgery within the previous 6 months.
  • Current lower extremity pain or musculoskeletal injury that may interfere with exercise performance.
  • Cardiovascular, vascular, neurological, or other medical conditions that may contraindicate blood flow restriction exercise.
  • Presence of skin lesions or conditions preventing placement of the blood flow restriction cuff or MOXY sensor.
  • Inability to complete either exercise condition or follow the study protocol.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
24 participants (estimated)

Study arms

  • Experimental
    BFR NHE-NHE

    Participants randomized to this sequence will perform conventional Nordic Hamstring Exercise during the first testing session. Following a 7-day washout period, they will perform Nordic Hamstring Exercise with blood flow restriction during the second testing session.

    Other: Nordic Hamstring Exercise · Other: Blood Flow Restriction Nordic Hamstring Exercise

  • Experimental
    NHE-BFR NHE

    Participants randomized to this sequence will perform Nordic Hamstring Exercise with blood flow restriction during the first testing session. Following a 7-day washout period, they will perform conventional Nordic Hamstring Exercise during the second testing session.

    Other: Nordic Hamstring Exercise · Other: Blood Flow Restriction Nordic Hamstring Exercise

Interventions

  • OtherNordic Hamstring Exercise

    Participants will perform a standardized Nordic Hamstring Exercise protocol under physiotherapist supervision. From a kneeling position with the ankles stabilized, participants will lower the trunk forward in a controlled manner while maintaining alignment of the trunk and hips.

  • OtherBlood Flow Restriction Nordic Hamstring Exercise

    Participants will perform the same standardized Nordic Hamstring Exercise protocol while individualized blood flow restriction is applied using a pneumatic cuff positioned on the proximal lower extremity.

06

What researchers measure

Primary outcomes

  1. Difference in Change in Hamstring Muscle Oxygen Saturation (Delta SmO₂) Between NHE and BFR-NHE

    Hamstring muscle oxygen saturation will be continuously measured using a wearable near-infrared spectroscopy device (MOXY) during conventional Nordic Hamstring Exercise and Blood Flow Restriction Nordic Hamstring Exercise. Delta SmO₂ will be calculated as the difference between baseline SmO₂ and the minimum SmO₂ recorded during each exercise condition. Greater negative change indicates greater muscle deoxygenation.

    Time frame: During each exercise session, with the two sessions separated by a 7-day washout period

  2. Difference in Minimum Hamstring Muscle Oxygen Saturation Between NHE and BFR-NHE

    The minimum hamstring muscle oxygen saturation value (SmO₂, %) recorded during each exercise condition will be obtained using the MOXY near-infrared spectroscopy device. Lower values indicate greater muscle deoxygenation.

    Time frame: During each exercise session, with the two sessions separated by a 7-day washout period

  3. Difference in Hamstring Muscle Oxygen Saturation During Recovery Between NHE and BFR-NHE

    Hamstring muscle oxygen saturation (SmO₂, %) will be recorded during the post-exercise recovery period following each exercise condition using the MOXY device.

    Time frame: Immediately after each exercise session during the recovery period, with sessions separated by a 7-day washout period

  4. Difference in Peak Hamstring Total Hemoglobin Between NHE and BFR-NHE

    Peak total hemoglobin concentration in the hamstring muscle will be recorded during each exercise condition using the MOXY near-infrared spectroscopy device.

    Time frame: During each exercise session, with the two sessions separated by a 7-day washout period.

  5. Difference in Change in Hamstring Total Hemoglobin Between NHE and BFR-NHE

    Change in total hemoglobin will be calculated as the difference between baseline total hemoglobin and peak total hemoglobin recorded during each exercise condition using the MOXY device.

    Time frame: During each exercise session, with the two sessions separated by a 7-day washout period.

  6. Difference in Post-Exercise Blood Lactate Concentration Between NHE and BFR-NHE

    Blood lactate concentration will be measured using a portable lactate analyzer following each exercise condition and reported in mmol/L. Higher values indicate a greater acute metabolic response.

    Time frame: Immediately after each exercise session, with the two sessions separated by a 7-day washout period

Secondary outcomes

  1. Difference in Rating of Perceived Exertion Between NHE and BFR-NHE

    Perceived exertion will be assessed using the Borg Rating of Perceived Exertion Scale following each exercise condition. Higher scores indicate greater perceived exertion.

    Time frame: Immediately after each exercise session, with the two sessions separated by a 7-day washout period

  2. Difference in the Number of Successfully Completed Nordic Hamstring Exercise Repetitions Between Conditions

    The number of Nordic Hamstring Exercise repetitions completed with the required technique will be recorded during each exercise condition. A higher number indicates better acute exercise performance.

    Time frame: During each exercise session, with the two sessions separated by a 7-day washout period

  3. Difference in Post-Exercise Hamstring Muscle Soreness Between NHE and BFR-NHE

    Hamstring muscle soreness will be assessed using an 11-point Numerical Rating Scale ranging from 0, indicating no soreness, to 10, indicating the worst imaginable soreness.

    Time frame: 24 hours after each exercise session

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jul 2026 (actual). Primary completion is estimated for Jul 2027, 12 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 13, 2026
First posted
Jul 20, 2026
StartActual
Jul 1, 2026
Primary completionEst.
Jul 2027
CompletionEst.
Aug 2027
Last update
Jul 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07715786
Lead sponsor
Toros University
Responsible party
Idil Esin Unlu (Assist. Prof. Dr., Toros University) — Principal investigator
First posted
Jul 20, 2026
Start date
Jul 1, 2026
Primary completion
Jul 2027 (estimated)
Completion
Aug 2027 (estimated)
Last update
Jul 20, 2026

Study contacts

İdil Ünlü, Assist. Prof. Dr.
Contact
idil.unlu@toros.edu.tr
+90 506 515 66 22

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion